|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Viral protein
|
 |
|
Title:
|
 |
Structure of the viral serpin crma
|
|
Structure:
|
 |
Ice inhibitor. Chain: a. Fragment: residues 1-305. Synonym: cytokine response modifier protein, crma. Engineered: yes. Ice inhibitor. Chain: b. Fragment: residues 306-341. Synonym: cytokine response modifier protein, crma.
|
|
Source:
|
 |
Cowpox virus. Organism_taxid: 10243. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008.
|
|
Biol. unit:
|
 |
Dimer (from
)
|
|
Resolution:
|
 |
|
2.26Å
|
R-factor:
|
0.228
|
R-free:
|
0.272
|
|
|
Authors:
|
 |
M.Renatus,Q.Zhou,H.R.Stennicke,S.J.Snipas,D.Turk,L.A.Bankston, R.C.Liddington,G.S.Salvesen
|
Key ref:
|
 |
M.Renatus
et al.
(2000).
Crystal structure of the apoptotic suppressor CrmA in its cleaved form.
Structure,
8,
789-797.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
15-May-00
|
Release date:
|
06-Sep-00
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains A, B:
E.C.?
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Structure
8:789-797
(2000)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of the apoptotic suppressor CrmA in its cleaved form.
|
|
M.Renatus,
Q.Zhou,
H.R.Stennicke,
S.J.Snipas,
D.Turk,
L.A.Bankston,
R.C.Liddington,
G.S.Salvesen.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
BACKGROUND: Cowpox virus expresses the serpin CrmA (cytokine response modifier
A) in order to avoid inflammatory and apoptotic responses of infected host
cells. The targets of CrmA are members of the caspase family of proteases that
either initiate the extrinsic pathway of apoptosis (caspases 8 and 10) or
trigger activation of the pro-inflammatory cytokines interleukin-1beta and
interleukin-18 (caspase 1). RESULTS: We have determined the structure of a
cleaved form of CrmA to 2.26 A resolution. CrmA has the typical fold of a
cleaved serpin, even though it lacks the N-terminal half of the A helix, the
entire D helix, and a portion of the E helix that are present in all other known
serpins. The reactive-site loop of CrmA was mutated to contain the optimal
substrate recognition sequence for caspase 3; however, the mutation only
marginally increased the ability of CrmA to inhibit caspase 3. Superposition of
the reactive-site loop of alpha1-proteinase inhibitor on the cleaved CrmA
structure provides a model for virgin CrmA that can be docked to caspase 1, but
not to caspase 3. CONCLUSIONS: CrmA exemplifies viral economy, selective
pressure having resulted in a 'minimal' serpin that lacks the regions not needed
for structural integrity or inhibitory activity. The docking model provides an
explanation for the selectivity of CrmA. Our demonstration that engineering
optimal substrate recognition sequences into the CrmA reactive-site loop fails
to generate a good caspase 3 inhibitor is consistent with the docking model.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
Figure 4.
Figure 4. Stereoview of the electron density. Parts of the
central b sheet A (strands 3A, 4A, 5A and 6A, right to left, and
turn s5As4A) are superimposed with the final 2F[o]-F[c]
electron-density map contoured at 0.8s. The atoms are colored by
type: blue, carbon; cyan, nitrogen; and red, oxygen. The figure
was made with the program BobScript [49].
|
 |
|
|
|
| |
The above figure is
reprinted
by permission from Cell Press:
Structure
(2000,
8,
789-797)
copyright 2000.
|
|
| |
Figure was
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
S.M.Best
(2008).
Viral subversion of apoptotic enzymes: escape from death row.
|
| |
Annu Rev Microbiol,
62,
171-192.
|
 |
|
|
|
|
 |
L.D.Cabrita,
J.A.Irving,
M.C.Pearce,
J.C.Whisstock,
and
S.P.Bottomley
(2007).
Aeropin from the extremophile Pyrobaculum aerophilum bypasses the serpin misfolding trap.
|
| |
J Biol Chem,
282,
26802-26809.
|
 |
|
|
|
|
 |
R.Swanson,
M.P.Raghavendra,
W.Zhang,
C.Froelich,
P.G.Gettins,
and
S.T.Olson
(2007).
Serine and cysteine proteases are translocated to similar extents upon formation of covalent complexes with serpins. Fluorescence perturbation and fluorescence resonance energy transfer mapping of the protease binding site in CrmA complexes with granzyme B and caspase-1.
|
| |
J Biol Chem,
282,
2305-2313.
|
 |
|
|
|
|
 |
I.Chowdhury,
B.Tharakan,
and
G.K.Bhat
(2006).
Current concepts in apoptosis: the physiological suicide program revisited.
|
| |
Cell Mol Biol Lett,
11,
506-525.
|
 |
|
|
|
|
 |
I.Millet,
F.S.Wong,
W.Gurr,
L.Wen,
W.Zawalich,
E.A.Green,
R.A.Flavell,
and
R.S.Sherwin
(2006).
Targeted expression of the anti-apoptotic gene CrmA to NOD pancreatic islets protects from autoimmune diabetes.
|
| |
J Autoimmun,
26,
7.
|
 |
|
|
|
|
 |
J.Dobó,
R.Swanson,
G.S.Salvesen,
S.T.Olson,
and
P.G.Gettins
(2006).
Cytokine response modifier a inhibition of initiator caspases results in covalent complex formation and dissociation of the caspase tetramer.
|
| |
J Biol Chem,
281,
38781-38790.
|
 |
|
|
|
|
 |
R.H.Law,
Q.Zhang,
S.McGowan,
A.M.Buckle,
G.A.Silverman,
W.Wong,
C.J.Rosado,
C.G.Langendorf,
R.N.Pike,
P.I.Bird,
and
J.C.Whisstock
(2006).
An overview of the serpin superfamily.
|
| |
Genome Biol,
7,
216.
|
 |
|
|
|
|
 |
I.N.Lavrik,
A.Golks,
and
P.H.Krammer
(2005).
Caspases: pharmacological manipulation of cell death.
|
| |
J Clin Invest,
115,
2665-2672.
|
 |
|
|
|
|
 |
L.D.Tesch,
M.P.Raghavendra,
T.Bedsted-Faarvang,
P.G.Gettins,
and
S.T.Olson
(2005).
Specificity and reactive loop length requirements for crmA inhibition of serine proteases.
|
| |
Protein Sci,
14,
533-542.
|
 |
|
|
|
|
 |
A.B.Werner,
S.W.Tait,
E.de Vries,
E.Eldering,
and
J.Borst
(2004).
Requirement for aspartate-cleaved bid in apoptosis signaling by DNA-damaging anti-cancer regimens.
|
| |
J Biol Chem,
279,
28771-28780.
|
 |
|
|
|
|
 |
T.H.Roberts,
J.Hejgaard,
N.F.Saunders,
R.Cavicchioli,
and
P.M.Curmi
(2004).
Serpins in unicellular Eukarya, Archaea, and Bacteria: sequence analysis and evolution.
|
| |
J Mol Evol,
59,
437-447.
|
 |
|
|
|
|
 |
H.Everett,
and
G.McFadden
(2002).
Poxviruses and apoptosis: a time to die.
|
| |
Curr Opin Microbiol,
5,
395-402.
|
 |
|
|
|
|
 |
H.R.Stennicke,
C.A.Ryan,
and
G.S.Salvesen
(2002).
Reprieval from execution: the molecular basis of caspase inhibition.
|
| |
Trends Biochem Sci,
27,
94.
|
 |
|
|
|
|
 |
L.Goyal
(2001).
Cell death inhibition: keeping caspases in check.
|
| |
Cell,
104,
805-808.
|
 |
|
|
|
|
 |
L.Jankova,
S.J.Harrop,
D.N.Saunders,
J.L.Andrews,
K.C.Bertram,
A.R.Gould,
M.S.Baker,
and
P.M.Curmi
(2001).
Crystal structure of the complex of plasminogen activator inhibitor 2 with a peptide mimicking the reactive center loop.
|
| |
J Biol Chem,
276,
43374-43382.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
Y.Suminami,
F.Kishi,
A.Murakami,
Y.Sakaguchi,
S.Nawata,
F.Numa,
and
H.Kato
(2001).
Novel forms of squamous cell carcinoma antigen transcripts produced by alternative splicing.
|
| |
Biochim Biophys Acta,
1519,
122-126.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |